Rocket Lab USA, Inc. (RKLB) is currently trading at $17.95 as of 2025-03-10. The stock is showing signs of being oversold, with RSI values of 32.03 (RSI_6), 33.13 (RSI_12), and 34.34 (RSI_14), all below the 50 threshold. The MACD is negative at -2.27, indicating bearish momentum. The stock is trading below its 20-day SMA of $23.63, which is a bearish signal.
Rocket Lab recently reported strong Q4 2024 results, with revenue of $132.4 million, beating estimates. However, the company provided weaker-than-expected Q1 2025 guidance, which has weighed on the stock. Despite this, Rocket Lab announced a successful moon landing mission, which is a positive catalyst. ARK Invest's sale of 76,331 shares has also impacted the stock price, causing a 3% drop. Analysts maintain a Moderate Buy rating with a target price of $25.72.
The Fibonacci levels for RKLB show resistance at $22.97 (R1) and $24.80 (R2), with support at $17.07 (S1) and $15.24 (S2). The pivot point is at $20.02.
Based on the technical indicators and news sentiment, RKLB is likely to experience a short-term rebound. The stock is oversold, and the successful moon landing mission could act as a catalyst. The target price for the next trading week is $20.50, with a stop-loss at $17.50.
Recommendation: Buy RKLB with a target price of $20.50 and a stop-loss at $17.50.
The price of RKLB is predicted to go up -0.01%, based on the high correlation periods with UBFO. The similarity of these two price pattern on the periods is 98.71%.
RKLB
UBFO
Morgan Stanley
2025-03-10
Price Target
$18 → $20
Upside
+16.82%
Wells Fargo
2025-03-03
Price Target
$22 → $21
Upside
+12.54%
Citigroup
2025-01-21
Price Target
$22 → $35
Upside
+11.93%